About Us
We are currently collecting Bio's for all 10 members of our Scientific Advisory Board and will have them posted here in the next few weeks. Thank you for your patience (Updated on August 24, 2010).
Scientific Advisory Board
Ryan Fiorini, Ph.D., MBA, MHA (Chairman)
Founder and Chief Operating Officer of Immunologix, Dr. Fiorini also serves as the chairman of the scientific advisory board. His scientific achievements include a Ph.D. in Microbiology and Immunology, focusing much of his thesis work on the therapeutic use of monoclonal antibodies in septic transplant patients. In addition to his scientific background in the antibody field,
Dr. Fiorini received his MBA and Masters in Health Administration (MHA), giving him a well rounded scientific and business background. Dr. Fiorini's focus for the company includes, business development, day-to-day operations of the laboratory and expanding opportunities to apply the technology platform.
Doug Carnes, Ph.D.
Founder and Chief Executive Officer, was the founder and CEO of Carnes Communications Inc (CCI), a Medical Education organization, providing CME education to medical professionals at healthcare conferences. Prior to the sale of CCI in 1996, it maintained 125 employees with $25M in annual revenue. Prior to CCI, Dr. Carnes spent 13 years with Smith Kline & French (SK&F) in marketing and sales. Dr. Carnes currently serves on two Board of Directors in various positions.
William Usinger, Ph.D.
Dr. Usinger is an immunologist, inventor and entrepreneur with expertise in drug development, assay development and validation, and technology evaluation and licensing. Dr. Usinger was the Founder and President of Immusine Labs and Cofounder and Vice President of R&D of Metabolex Corporation. For the past 12 years, Bill has led therapeutic antibody R&D, serving as the Department Head of ImmunoBiology at FibroGen and as Research Director in the Department of Biotherapeutics at Chiron/Novartis. Dr. Usinger currently is a scientific consultant to several biotechnology companies and is VP R&D for Trellis Bioscience.